Global Long-acting Reversible Contraceptives (LARCs) Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Long-acting Reversible Contraceptives (LARCs) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Long-acting Reversible Contraceptives (LARCs) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Long-acting Reversible Contraceptives (LARCs) by Country/Region, 2017, 2022 & 2028

2.2 Long-acting Reversible Contraceptives (LARCs) Segment by Type

2.2.1 Hormonal Intrauterine Devices

2.2.2 Copper Intrauterine Devices

2.2.3 Contraceptive Implants

2.2.4 Others

2.3 Long-acting Reversible Contraceptives (LARCs) Sales by Type

2.3.1 Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2017-2022)

2.3.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Long-acting Reversible Contraceptives (LARCs) Sale Price by Type (2017-2022)

2.4 Long-acting Reversible Contraceptives (LARCs) Segment by Application

2.4.1 Age 20-24

2.4.2 Age 25-34

2.4.3 Age 35-44

2.4.4 Others

2.5 Long-acting Reversible Contraceptives (LARCs) Sales by Application

2.5.1 Global Long-acting Reversible Contraceptives (LARCs) Sale Market Share by Application (2017-2022)

2.5.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Long-acting Reversible Contraceptives (LARCs) Sale Price by Application (2017-2022)

3 Global Long-acting Reversible Contraceptives (LARCs) by Company

3.1 Global Long-acting Reversible Contraceptives (LARCs) Breakdown Data by Company

3.1.1 Global Long-acting Reversible Contraceptives (LARCs) Annual Sales by Company (2020-2022)

3.1.2 Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Company (2020-2022)

3.2 Global Long-acting Reversible Contraceptives (LARCs) Annual Revenue by Company (2020-2022)

3.2.1 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Company (2020-2022)

3.2.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Company (2020-2022)

3.3 Global Long-acting Reversible Contraceptives (LARCs) Sale Price by Company

3.4 Key Manufacturers Long-acting Reversible Contraceptives (LARCs) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Long-acting Reversible Contraceptives (LARCs) Product Location Distribution

3.4.2 Players Long-acting Reversible Contraceptives (LARCs) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Long-acting Reversible Contraceptives (LARCs) by Geographic Region

4.1 World Historic Long-acting Reversible Contraceptives (LARCs) Market Size by Geographic Region (2017-2022)

4.1.1 Global Long-acting Reversible Contraceptives (LARCs) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Long-acting Reversible Contraceptives (LARCs) Annual Revenue by Geographic Region

4.2 World Historic Long-acting Reversible Contraceptives (LARCs) Market Size by Country/Region (2017-2022)

4.2.1 Global Long-acting Reversible Contraceptives (LARCs) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Long-acting Reversible Contraceptives (LARCs) Annual Revenue by Country/Region

4.3 Americas Long-acting Reversible Contraceptives (LARCs) Sales Growth

4.4 APAC Long-acting Reversible Contraceptives (LARCs) Sales Growth

4.5 Europe Long-acting Reversible Contraceptives (LARCs) Sales Growth

4.6 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Growth

5 Americas

5.1 Americas Long-acting Reversible Contraceptives (LARCs) Sales by Country

5.1.1 Americas Long-acting Reversible Contraceptives (LARCs) Sales by Country (2017-2022)

5.1.2 Americas Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2017-2022)

5.2 Americas Long-acting Reversible Contraceptives (LARCs) Sales by Type

5.3 Americas Long-acting Reversible Contraceptives (LARCs) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Long-acting Reversible Contraceptives (LARCs) Sales by Region

6.1.1 APAC Long-acting Reversible Contraceptives (LARCs) Sales by Region (2017-2022)

6.1.2 APAC Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2017-2022)

6.2 APAC Long-acting Reversible Contraceptives (LARCs) Sales by Type

6.3 APAC Long-acting Reversible Contraceptives (LARCs) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Long-acting Reversible Contraceptives (LARCs) by Country

7.1.1 Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2017-2022)

7.1.2 Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2017-2022)

7.2 Europe Long-acting Reversible Contraceptives (LARCs) Sales by Type

7.3 Europe Long-acting Reversible Contraceptives (LARCs) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) by Country

8.1.1 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2017-2022)

8.2 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales by Type

8.3 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Long-acting Reversible Contraceptives (LARCs)

10.3 Manufacturing Process Analysis of Long-acting Reversible Contraceptives (LARCs)

10.4 Industry Chain Structure of Long-acting Reversible Contraceptives (LARCs)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Long-acting Reversible Contraceptives (LARCs) Distributors

11.3 Long-acting Reversible Contraceptives (LARCs) Customer

12 World Forecast Review for Long-acting Reversible Contraceptives (LARCs) by Geographic Region

12.1 Global Long-acting Reversible Contraceptives (LARCs) Market Size Forecast by Region

12.1.1 Global Long-acting Reversible Contraceptives (LARCs) Forecast by Region (2023-2028)

12.1.2 Global Long-acting Reversible Contraceptives (LARCs) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Long-acting Reversible Contraceptives (LARCs) Forecast by Type

12.7 Global Long-acting Reversible Contraceptives (LARCs) Forecast by Application

13 Key Players Analysis

13.1 Bayer

13.1.1 Bayer Company Information

13.1.2 Bayer Long-acting Reversible Contraceptives (LARCs) Product Offered

13.1.3 Bayer Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bayer Main Business Overview

13.1.5 Bayer Latest Developments

13.2 Merck

13.2.1 Merck Company Information

13.2.2 Merck Long-acting Reversible Contraceptives (LARCs) Product Offered

13.2.3 Merck Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck Main Business Overview

13.2.5 Merck Latest Developments

13.3 Cooper Companies

13.3.1 Cooper Companies Company Information

13.3.2 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product Offered

13.3.3 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Cooper Companies Main Business Overview

13.3.5 Cooper Companies Latest Developments

13.4 AbbVie Allergan

13.4.1 AbbVie Allergan Company Information

13.4.2 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product Offered

13.4.3 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 AbbVie Allergan Main Business Overview

13.4.5 AbbVie Allergan Latest Developments

13.5 Yantai JiShengYaoXie

13.5.1 Yantai JiShengYaoXie Company Information

13.5.2 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product Offered

13.5.3 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Yantai JiShengYaoXie Main Business Overview

13.5.5 Yantai JiShengYaoXie Latest Developments

13.6 H & J Medical

13.6.1 H & J Medical Company Information

13.6.2 H & J Medical Long-acting Reversible Contraceptives (LARCs) Product Offered

13.6.3 H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 H & J Medical Main Business Overview

13.6.5 H & J Medical Latest Developments

13.7 HRA Pharma

13.7.1 HRA Pharma Company Information

13.7.2 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product Offered

13.7.3 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 HRA Pharma Main Business Overview

13.7.5 HRA Pharma Latest Developments

13.8 Pregna

13.8.1 Pregna Company Information

13.8.2 Pregna Long-acting Reversible Contraceptives (LARCs) Product Offered

13.8.3 Pregna Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Pregna Main Business Overview

13.8.5 Pregna Latest Developments

13.9 ASPIVIX

13.9.1 ASPIVIX Company Information

13.9.2 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product Offered

13.9.3 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 ASPIVIX Main Business Overview

13.9.5 ASPIVIX Latest Developments

13.10 Shanghai Dahua Pharmaceuticals

13.10.1 Shanghai Dahua Pharmaceuticals Company Information

13.10.2 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product Offered

13.10.3 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Shanghai Dahua Pharmaceuticals Main Business Overview

13.10.5 Shanghai Dahua Pharmaceuticals Latest Developments

13.11 Williams Medical Supplies

13.11.1 Williams Medical Supplies Company Information

13.11.2 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product Offered

13.11.3 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Williams Medical Supplies Main Business Overview

13.11.5 Williams Medical Supplies Latest Developments

13.12 Laboratoire 7 MED

13.12.1 Laboratoire 7 MED Company Information

13.12.2 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product Offered

13.12.3 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Laboratoire 7 MED Main Business Overview

13.12.5 Laboratoire 7 MED Latest Developments

13.13 Durbin

13.13.1 Durbin Company Information

13.13.2 Durbin Long-acting Reversible Contraceptives (LARCs) Product Offered

13.13.3 Durbin Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Durbin Main Business Overview

13.13.5 Durbin Latest Developments

13.14 Laboratoire CCD

13.14.1 Laboratoire CCD Company Information

13.14.2 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product Offered

13.14.3 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Laboratoire CCD Main Business Overview

13.14.5 Laboratoire CCD Latest Developments

13.15 Prosan

13.15.1 Prosan Company Information

13.15.2 Prosan Long-acting Reversible Contraceptives (LARCs) Product Offered

13.15.3 Prosan Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Prosan Main Business Overview

13.15.5 Prosan Latest Developments

13.16 OCON

13.16.1 OCON Company Information

13.16.2 OCON Long-acting Reversible Contraceptives (LARCs) Product Offered

13.16.3 OCON Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 OCON Main Business Overview

13.16.5 OCON Latest Developments

14 Research Findings and Conclusion

Table 1. Long-acting Reversible Contraceptives (LARCs) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Long-acting Reversible Contraceptives (LARCs) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Hormonal Intrauterine Devices

Table 4. Major Players of Copper Intrauterine Devices

Table 5. Major Players of Contraceptive Implants

Table 6. Major Players of Others

Table 7. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2022) & (K Units)

Table 8. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2017-2022)

Table 9. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2017-2022) & ($ million)

Table 10. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2017-2022)

Table 11. Global Long-acting Reversible Contraceptives (LARCs) Sale Price by Type (2017-2022) & (US$/Unit)

Table 12. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2017-2022) & (K Units)

Table 13. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2017-2022)

Table 14. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2017-2022)

Table 15. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2017-2022)

Table 16. Global Long-acting Reversible Contraceptives (LARCs) Sale Price by Application (2017-2022) & (US$/Unit)

Table 17. Global Long-acting Reversible Contraceptives (LARCs) Sales by Company (2020-2022) & (K Units)

Table 18. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Company (2020-2022)

Table 19. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Company (2020-2022)

Table 21. Global Long-acting Reversible Contraceptives (LARCs) Sale Price by Company (2020-2022) & (US$/Unit)

Table 22. Key Manufacturers Long-acting Reversible Contraceptives (LARCs) Producing Area Distribution and Sales Area

Table 23. Players Long-acting Reversible Contraceptives (LARCs) Products Offered

Table 24. Long-acting Reversible Contraceptives (LARCs) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Long-acting Reversible Contraceptives (LARCs) Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share Geographic Region (2017-2022)

Table 29. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Long-acting Reversible Contraceptives (LARCs) Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country/Region (2017-2022)

Table 33. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Long-acting Reversible Contraceptives (LARCs) Sales by Country (2017-2022) & (K Units)

Table 36. Americas Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2017-2022)

Table 37. Americas Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2017-2022)

Table 39. Americas Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2022) & (K Units)

Table 40. Americas Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2017-2022)

Table 41. Americas Long-acting Reversible Contraceptives (LARCs) Sales by Application (2017-2022) & (K Units)

Table 42. Americas Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2017-2022)

Table 43. APAC Long-acting Reversible Contraceptives (LARCs) Sales by Region (2017-2022) & (K Units)

Table 44. APAC Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2017-2022)

Table 45. APAC Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region (2017-2022)

Table 47. APAC Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2022) & (K Units)

Table 48. APAC Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2017-2022)

Table 49. APAC Long-acting Reversible Contraceptives (LARCs) Sales by Application (2017-2022) & (K Units)

Table 50. APAC Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2017-2022)

Table 51. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2017-2022) & (K Units)

Table 52. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2017-2022)

Table 53. Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2017-2022)

Table 55. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2022) & (K Units)

Table 56. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2017-2022)

Table 57. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Application (2017-2022) & (K Units)

Table 58. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Long-acting Reversible Contraceptives (LARCs)

Table 68. Key Market Challenges & Risks of Long-acting Reversible Contraceptives (LARCs)

Table 69. Key Industry Trends of Long-acting Reversible Contraceptives (LARCs)

Table 70. Long-acting Reversible Contraceptives (LARCs) Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Long-acting Reversible Contraceptives (LARCs) Distributors List

Table 73. Long-acting Reversible Contraceptives (LARCs) Customer List

Table 74. Global Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Forecast by Region

Table 76. Global Long-acting Reversible Contraceptives (LARCs) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Long-acting Reversible Contraceptives (LARCs) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Long-acting Reversible Contraceptives (LARCs) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Long-acting Reversible Contraceptives (LARCs) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Long-acting Reversible Contraceptives (LARCs) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Long-acting Reversible Contraceptives (LARCs) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share Forecast by Application (2023-2028)

Table 94. Bayer Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors

Table 95. Bayer Long-acting Reversible Contraceptives (LARCs) Product Offered

Table 96. Bayer Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 97. Bayer Main Business

Table 98. Bayer Latest Developments

Table 99. Merck Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors

Table 100. Merck Long-acting Reversible Contraceptives (LARCs) Product Offered

Table 101. Merck Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 102. Merck Main Business

Table 103. Merck Latest Developments

Table 104. Cooper Companies Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors

Table 105. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product Offered

Table 106. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 107. Cooper Companies Main Business

Table 108. Cooper Companies Latest Developments

Table 109. AbbVie Allergan Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors

Table 110. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product Offered

Table 111. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 112. AbbVie Allergan Main Business

Table 113. AbbVie Allergan Latest Developments

Table 114. Yantai JiShengYaoXie Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors

Table 115. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product Offered

Table 116. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 117. Yantai JiShengYaoXie Main Business

Table 118. Yantai JiShengYaoXie Latest Developments

Table 119. H & J Medical Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors

Table 120. H & J Medical Long-acting Reversible Contraceptives (LARCs) Product Offered

Table 121. H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 122. H & J Medical Main Business

Table 123. H & J Medical Latest Developments

Table 124. HRA Pharma Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors

Table 125. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product Offered

Table 126. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 127. HRA Pharma Main Business

Table 128. HRA Pharma Latest Developments

Table 129. Pregna Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors

Table 130. Pregna Long-acting Reversible Contraceptives (LARCs) Product Offered

Table 131. Pregna Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 132. Pregna Main Business

Table 133. Pregna Latest Developments

Table 134. ASPIVIX Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors

Table 135. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product Offered

Table 136. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 137. ASPIVIX Main Business

Table 138. ASPIVIX Latest Developments

Table 139. Shanghai Dahua Pharmaceuticals Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors

Table 140. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product Offered

Table 141. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 142. Shanghai Dahua Pharmaceuticals Main Business

Table 143. Shanghai Dahua Pharmaceuticals Latest Developments

Table 144. Williams Medical Supplies Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors

Table 145. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product Offered

Table 146. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 147. Williams Medical Supplies Main Business

Table 148. Williams Medical Supplies Latest Developments

Table 149. Laboratoire 7 MED Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors

Table 150. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product Offered

Table 151. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 152. Laboratoire 7 MED Main Business

Table 153. Laboratoire 7 MED Latest Developments

Table 154. Durbin Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors

Table 155. Durbin Long-acting Reversible Contraceptives (LARCs) Product Offered

Table 156. Durbin Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 157. Durbin Main Business

Table 158. Durbin Latest Developments

Table 159. Laboratoire CCD Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors

Table 160. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product Offered

Table 161. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 162. Laboratoire CCD Main Business

Table 163. Laboratoire CCD Latest Developments

Table 164. Prosan Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors

Table 165. Prosan Long-acting Reversible Contraceptives (LARCs) Product Offered

Table 166. Prosan Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 167. Prosan Main Business

Table 168. Prosan Latest Developments

Table 169. OCON Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors

Table 170. OCON Long-acting Reversible Contraceptives (LARCs) Product Offered

Table 171. OCON Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 172. OCON Main Business

Table 173. OCON Latest Developments

List of Figures

Figure 1. Picture of Long-acting Reversible Contraceptives (LARCs)

Figure 2. Long-acting Reversible Contraceptives (LARCs) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Long-acting Reversible Contraceptives (LARCs) Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Long-acting Reversible Contraceptives (LARCs) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Hormonal Intrauterine Devices

Figure 10. Product Picture of Copper Intrauterine Devices

Figure 11. Product Picture of Contraceptive Implants

Figure 12. Product Picture of Others

Figure 13. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type in 2021

Figure 14. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2017-2022)

Figure 15. Long-acting Reversible Contraceptives (LARCs) Consumed in Age 20-24

Figure 16. Global Long-acting Reversible Contraceptives (LARCs) Market: Age 20-24 (2017-2022) & (K Units)

Figure 17. Long-acting Reversible Contraceptives (LARCs) Consumed in Age 25-34

Figure 18. Global Long-acting Reversible Contraceptives (LARCs) Market: Age 25-34 (2017-2022) & (K Units)

Figure 19. Long-acting Reversible Contraceptives (LARCs) Consumed in Age 35-44

Figure 20. Global Long-acting Reversible Contraceptives (LARCs) Market: Age 35-44 (2017-2022) & (K Units)

Figure 21. Long-acting Reversible Contraceptives (LARCs) Consumed in Others

Figure 22. Global Long-acting Reversible Contraceptives (LARCs) Market: Others (2017-2022) & (K Units)

Figure 23. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2017-2022)

Figure 24. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application in 2021

Figure 25. Long-acting Reversible Contraceptives (LARCs) Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Company in 2021

Figure 27. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Geographic Region in 2021

Figure 29. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2017-2022)

Figure 30. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country/Region in 2021

Figure 31. Americas Long-acting Reversible Contraceptives (LARCs) Sales 2017-2022 (K Units)

Figure 32. Americas Long-acting Reversible Contraceptives (LARCs) Revenue 2017-2022 ($ Millions)

Figure 33. APAC Long-acting Reversible Contraceptives (LARCs) Sales 2017-2022 (K Units)

Figure 34. APAC Long-acting Reversible Contraceptives (LARCs) Revenue 2017-2022 ($ Millions)

Figure 35. Europe Long-acting Reversible Contraceptives (LARCs) Sales 2017-2022 (K Units)

Figure 36. Europe Long-acting Reversible Contraceptives (LARCs) Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales 2017-2022 (K Units)

Figure 38. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue 2017-2022 ($ Millions)

Figure 39. Americas Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country in 2021

Figure 40. Americas Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country in 2021

Figure 41. United States Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region in 2021

Figure 46. APAC Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Regions in 2021

Figure 47. China Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country in 2021

Figure 54. Europe Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country in 2021

Figure 55. Germany Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country in 2021

Figure 62. Egypt Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Long-acting Reversible Contraceptives (LARCs) in 2021

Figure 68. Manufacturing Process Analysis of Long-acting Reversible Contraceptives (LARCs)

Figure 69. Industry Chain Structure of Long-acting Reversible Contraceptives (LARCs)

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles